SA

Shakuntala Awadheshkumar Sinha

Director Director DIN 02339170
DIN 02339170 First appointment Apr 2002 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Apr 2002
Shareholding value •••• Premium profile

About Shakuntala Awadheshkumar Sinha

Data last updated:

Shakuntala Awadheshkumar Sinha was a Director at Lok-Beta Pharmaceuticals (India )Private Limited (2002–2017) and Director at Bioveeta Laboratories Private Limited (2004–2014). The companies operate in Pharma.

DIN 02339170
Primary Designation Director
Industry Pharma
First Appointment 18 Apr 2002

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Apr 20022002₹60.20 Cr (FY 2024)Active
Director25 Jun 20042004₹1.29 Cr (FY 2024)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lok-Beta Pharmaceuticals (India )Private Limited
Bioveeta Laboratories Private Limited
Premium access

Shareholding and investment profile for Shakuntala Awadheshkumar Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shakuntala Awadheshkumar Sinha

Shakuntala Awadheshkumar Sinha was first appointed on 18 Apr 2002 as Director at Lok-Beta Pharmaceuticals (India )Private Limited. The most recent appointment on record is 25 Jun 2004 at Bioveeta Laboratories Private Limited.

Shakuntala Awadheshkumar Sinha held 2 earlier board appointments: Lok-Beta Pharmaceuticals (India )Private Limited (Director, 18 Apr 2002 to 01 Mar 2017); Bioveeta Laboratories Private Limited (Director, 25 Jun 2004 to 18 Nov 2014).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available